laitimes

Ampicillin sodium for injection of Harbin Pharmaceutical Co., Ltd. passed the consistency evaluation of generic drugs

Shanghai Securities News China Securities Network News (reporter Confucius Ziyuan) Harbin Pharmaceutical Shares announced that the company's branch Harbin Pharmaceutical General Factory received the "Notice of Approval of Drug Supplement Application" issued by the State Drug Administration on ampicillin sodium for injection, and the drug passed the consistency evaluation of the quality and efficacy of generic drugs. The drug is suitable for respiratory tract infections, gastrointestinal infections, urinary tract infections, soft tissue infections, endocarditis, meningitis, sepsis and so on caused by sensitive bacteria.

Ampicillin sodium for injection of Harbin Pharmaceutical Co., Ltd. passed the consistency evaluation of generic drugs

Read on